These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9545222)
41. Inhibition of alpha-hemolysin expression by resveratrol attenuates Staphylococcus aureus virulence. Tang F; Li L; Meng XM; Li B; Wang CQ; Wang SQ; Wang TL; Tian YM Microb Pathog; 2019 Feb; 127():85-90. PubMed ID: 30468853 [TBL] [Abstract][Full Text] [Related]
42. Quantification of virulence-associated gene transcripts in epidemic methicillin resistant Staphylococcus aureus by real-time PCR. Sabersheikh S; Saunders NA Mol Cell Probes; 2004 Feb; 18(1):23-31. PubMed ID: 15036366 [TBL] [Abstract][Full Text] [Related]
43. Comparative homology model building and docking evaluation for RNA III inhibiting peptide of Multi drug resistant Staphylococcus aureus strain MRSA252. Mevada V; Patel R; Patel B; Chaudhari R Comput Biol Chem; 2018 Apr; 73():189-199. PubMed ID: 29494927 [TBL] [Abstract][Full Text] [Related]
46. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527 [TBL] [Abstract][Full Text] [Related]
47. Staphylococcus aureus Regulatory RNAs as Potential Biomarkers for Bloodstream Infections. Bordeau V; Cady A; Revest M; Rostan O; Sassi M; Tattevin P; Donnio PY; Felden B Emerg Infect Dis; 2016 Sep; 22(9):1570-8. PubMed ID: 27224202 [TBL] [Abstract][Full Text] [Related]
48. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection. Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748 [TBL] [Abstract][Full Text] [Related]
49. The expression of LytM is down-regulated by RNAIII in Staphylococcus aureus. Chunhua M; Yu L; Yaping G; Jie D; Qiang L; Xiaorong T; Guang Y J Basic Microbiol; 2012 Dec; 52(6):636-41. PubMed ID: 22581788 [TBL] [Abstract][Full Text] [Related]
50. RNAIII is linked with the pentose phosphate pathway through the activation of RpiRc in Hallier M; Bronsard J; Dréano S; Sassi M; Cattoir V; Felden B; Augagneur Y mSphere; 2024 May; 9(5):e0034823. PubMed ID: 38591898 [No Abstract] [Full Text] [Related]
51. Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression. Benito Y; Kolb FA; Romby P; Lina G; Etienne J; Vandenesch F RNA; 2000 May; 6(5):668-79. PubMed ID: 10836788 [TBL] [Abstract][Full Text] [Related]
52. Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII). Oscarsson J; Tegmark-Wisell K; Arvidson S Int J Med Microbiol; 2006 Oct; 296(6):365-80. PubMed ID: 16782403 [TBL] [Abstract][Full Text] [Related]
53. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467 [TBL] [Abstract][Full Text] [Related]
54. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881 [TBL] [Abstract][Full Text] [Related]